Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Golcadomide Non-Hodgkin Lymphoma	University of Pittsburgh	P2	B (62)
htd1801 Metabolic Dysfunction-Associated Steatohepatitis	HighTide Biopharma Pty Ltd	P2	B (62)
Humax-Cd20 Burkitt Lymphoma	M.D. Anderson Cancer Center	P2	B (62)
Humax-Cd20 Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	B (62)
Imiquimod Melanoma	Toray Industries, Inc	P2	B (62)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Breast Cancer	National Cancer Institute (NCI)	P2	B (62)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Fallopian Tube Carcinoma	National Cancer Institute (NCI)	P2	B (62)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Primary Peritoneal Carcinoma	National Cancer Institute (NCI)	P2	B (62)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Head And Neck Cancer	Bolt Biotherapeutics, Inc.	P2	B (62)
Inidascamine Schizophrenia	Recognify Life Sciences	P2	B (62)
Inotuzumab Ozogamicin B-Cell Non-Hodgkin Lymphoma	Dana-Farber Cancer Institute	P2	B (62)
Ipilimumab Hematopoietic And Lymphoid Cell Neoplasm	M.D. Anderson Cancer Center	P2	B (62)
Ipilimumab Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P2	B (62)
Ipilimumab Ovarian Carcinoma	National Cancer Institute (NCI)	P2	B (62)
Ipilimumab Wilms Tumor	Children's National Research Institute	P2	B (62)
Irinotecan Renal Cell Carcinoma	Toray Industries, Inc	P2	B (62)
IVABRADINE Long COVID-19	Kanecia Obie Zimmerman	P2	B (62)
Ivosidenib Myeloproliferative Neoplasm	M.D. Anderson Cancer Center	P2	B (62)
LENALIDOMIDE Hodgkins Lymphoma	M.D. Anderson Cancer Center	P2	B (62)
LENALIDOMIDE Leukemia	M.D. Anderson Cancer Center	P2	B (62)
LENALIDOMIDE Kidney Failure	Hellenic Society of Hematology	P2	B (62)
LEVOFOLINIC ACID Malignant Pancreatic Neoplasm	Zhejiang University	P2	B (62)
LY-2562175 Metabolic Dysfunction-Associated Steatohepatitis	Terns, Inc.	P2	B (62)
Maralixibat Progressive Familial Intrahepatic Cholestasis	Mirum Pharmaceuticals, Inc.	P2	B (62)
MELATONIN Long COVID-19	Duke University	P2	B (62)

Showing 1201 to 1225 of 13,155 assets

PreviousPage 49 of 527Next